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Background: Endoscopic thyroidectomy has been applied prudently to malignant thyroid tumors. The purpose of
our study was to compare the surgical outcomes of endoscopic thyroidectomy (ET) and conventional open
thyroidectomy (COT) for micropapillary thyroid carcinoma.
Methods: From October 2002 to December 2008, 78 patients underwent unilateral lobectomy and isthmectomy
with central lymph node dissection for papillary thyroid microcarcinoma. Of these, 37 patients underwent ET and
41patients COT. Surgical outcomes, including operation time, number of retrieved lymph nodes, postoperative
complication rate and patients’ satisfaction with the cosmetic results, were analyzed.
Results: The mean age of the patients was 42.3 ± 7.6 years in the ET group and 49.0 ± 10.8 years in the OT group
(P = 0.003). The operation time was shorter in the COT group (112.3 ± 14min) than in the ET group (138.4 ± 36.9
min, P< 0.01). However, there were no significant differences in tumor size (0.5 ± 0.231vs. 0.41 ± 0.264cm, P =
0.116), number of retrieved lymph nodes (3.63 ± 2.1vs. 3.82 ± 3.28, P = 0.78) or postoperative hospital stay (3.35 ±
0.94vs. 3.17 ± 1.16 days, P = 0.457). Patients in the ET group experienced more pain than those in the COT group at
1 and 7 days after the operation as evaluated by a visual analog scale (P = 0.037, 0.026). Cosmetically, patients in
the ET group were very satisfied with the operative procedure according to the questionnaire we used (1.43 ±
0.55vs. 3.21 ± 0.72, P< 0.001). The mean follow-up period was 54.3 months in the ET group and 47.4 months in the
COT group, and each group exhibited one case of tumor recurrence detected at the other thyroid lobe within 2
years.
Conclusions: Large series of prospective studies and long-term follow-up are needed, but the results of ET using
the axillary approach for micropapillary thyroid carcinoma were not inferiortothose using COT, and it might be a
safe and feasible procedure with good cosmetic results.
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Figure 1 Operative view of ipsilateral axillary approach
endoscopic thyroidectomy. Two trocars (5mm and 10mm) are
inserted through axillary incisions. CO2 gas is insufflated via one 10-
mm trocar, and the 10-mm rigid endoscope is inserted via this
trocar.
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With the development of minimally invasive surgery, the
use of endoscopic surgery for head and neck disease has
also developed. Endoscopic neck surgery was first intro-
duced by Gagner in 1996 [1], and Huscher performed
the first endoscopic thyroidectomy in 1997 [2]. There-
after, various endoscopic operative methods, including
axillary, breast and anterior chest approaches,were intro-
duced by many surgeons. Initially, endoscopic thyroid
surgery was thought to be appropriate only for benign
thyroid diseasesand contraindicated in thyroid cancer
patients because a complete thyroidectomy could not be
adequately performed via endoscopic means [3]. How-
ever, the prognosis of papillary thyroid carcinoma is rela-
tively good.More females suffer from thyroid tumors
than males. Because of its cosmetic advantages, ET has
been carefully and gradually appliedto thyroid malignan-
cies. As experience is accumulating and techniques are
being developed, the indications for endoscopic thyroi-
dectomy for thyroid malignancies can be expanded.The
aim of this study was to compare endoscopic lobectomy
and isthmectomy with ipsilateral central neck dissection
by the axillary approach with the conventional open
method in terms of the surgical outcomes and long-term
courses for papillary thyroid microcarcinoma.
Methods
From October 2002 to December 2008, a total of 41
patients with papillary thyroid microcarcinoma were
operated on using the conventional open approach at
Bucheon St. Mary’s Hospital. Additionally, in the same
period, a series of 37 patients with papillary thyroid
microcarcinoma underwent endoscopic thyroidectomy
by the axillary approach at the same institution. Our
indications for endoscopic thyroidectomy are as follows:
tumor size not exceeding 1cm and no evidence of lymph
node metastasis or local invasion on preoperative ultra-
sonography, computed tomography (CT) and physical
examination.
All procedures were performed by one surgeon (K.Y.
S.)andcarried out based strictly on patients’ individual
decisions after giving informed consent concerning the
surgical risks. Before the operations, we described the
operative methods and differences between ET and
COT, and each patient chose his or her own procedure.
We analyzed the medical records of all patients retro-
spectively and evaluated surgical outcomes such as hos-
pital day, operative time, complications, number of
retrieved lymph nodes, tumor size and cosmetic results
in the ET compared to the COT group.
The satisfaction with cosmetic results was analyzed
quantitatively using a scoring systemthat ranged from 1
to 4(1, extremely; 2, fairly; 3,normal; 4: not at all) that
was rated by patients at the outpatient clinic 6 monthsafter the operation. The International Review Board of
The Catholic University of Korea, Bucheon St. Mary’s
Hospital, approved this study protocol.
Surgical procedures
Endoscopic thyroidectomy
Patients in the ET group underwent endoscopic lobec-
tomy and isthmectomy with central lymph node dissec-
tion under general endotracheal anesthesia. The arm on
the side of the ipsilateral nodule was raised, and the ax-
illa was completely exposed. A diluted epinephrine solu-
tion (1:300,000) was injected into the subcutaneous layer
of the anterior chest and cervical skin. A 30–40-mm
skin incision was made in the axilla, and the lower layer
of the platysma was exposed through the upper portion
of the pectoralis major muscle. Trocars (one 10mm and
one 5mm) were inserted into this incision, and a purse-
string suture was placed to prevent gas leakage and slip-
ping of the trocars out of the wound. Carbon dioxide
(CO2) gas was then insufflated up to 6mmHg, and a 30°
10-mm rigid laparoscope was inserted into the 10-mm
trocar. After adequate dissecting, one more 5-mm trocar
was inserted near the 30-mm skin incision in the anter-
ior axillary line (Figure 1). Endoscopic scissors were used
for additional blunt and sharp dissection to enlarge the
subplatysmal space.
After the sternocleidomastoid muscle and the strap
muscle had been identified, the medial border of the
sternocleidomastoid muscle was dissected from the strap
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thyroid had been exposed, the upper pole of the thyroid
was drawn downward, and superior thyroid vessels were
identified and individually divided close to the thyroid to
avoid injuring the external branch of the superior laryn-
geal nerve. During dissection, the superior parathyroid
gland was identified and left intact.
Next, the thyroid was retracted medially, and the mid-
dle thyroid vein was identified and divided carefully.
Careful dissection was performed to identify the inferior
thyroid artery and the recurrent laryngeal nerve. The in-
ferior thyroid artery was divided close to the thyroid,
and the whole course of the recurrent laryngeal nerve
was dissected (Figure 2). During the division of the infer-
ior thyroid artery and dissection of the recurrent laryn-
geal nerve, the inferior parathyroid gland was identified
and left intact. After the inferior thyroid vein and thyro-
thymic ligament had been divided, the thyroid was
retracted upward and medially. The lymph nodes of the
central compartment were carefully dissected to avoid
injury to the RLN. Finally, the thyroid was dissected
from the trachea, and the isthmus was cut with a har-
monic scalpel.
The specimen was extracted through the 30-mm skin
incision. Before completing the operation, a 3-mm
closed suction drain was placed under the platysma on
the site of the most inferior 5-mm trocar in the axilla.
The wounds were closed by tightly suturing theFigure 2 Lateral view of the operative field during the
operation. The recurrent laryngeal nerve was separated carefully
from the thyroid gland, and the inferior thyroid artery, which
crossed the recurrent laryngeal nerve,was divided with a harmonic
scalpel. a Superior parathyroid gland; b inferior thyroid artery;
c recurrent laryngeal nerve.subcutaneous skin with 4–0 absorbable monofilament
sutures using an atraumatic needle, followed by place-
ment of Steri-Strips.Open thyroidectomy
Patients in the COT group underwent conventional open
thyroid lobectomy and isthmectomy with central lymph
node dissection in the supine position with neck exten-
sion under general endotracheal anesthesia. A 6–8-cm
transverse collar skin incision was made in the midline
of the anterior neck 2cm above the sternal notch
(Figure 3). The lower layer of the platysma was exposed,
and subplatysmal flap dissection was performed from
the sternal notch to the level of the hyoid bone super-
iorly. The midline of the strap muscles was divided verti-
cally, and the thyroid gland was exposed. Dissection of
the thyroid and division of the thyroid vessels and par-
enchyma were performed with electrocautery and
ligation. In all cases, the recurrent laryngeal nerve and
parathyroid glands were identified in the operative field.
The wounds were closed with absorbable suture material
by an interrupted subcutical suture method.Postoperative care
There was no difference between the groups in post-
operative care except for the closed drain in the ET
group,which was usually removed on day 2 after the op-
eration. Patients without any complications were usually
discharged on day 2 after the operation.Figure 3 Incision for conventional open thyroidectomy.
The length of the incision is 6.0 cm.
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The two groups were compared by Student’s t-test for
continuous variables and expressed as the mean ± SD.
Categorical variables were analyzed by chi-square test.
P< 0.05 was considered significant. All statistical ana-
lyses were performed using the Statistical Package for
the Social Sciences (SPSS), version 15.0, for Windows
(SPSS, Inc., Chicago, IL, USA).
Results
The clinicopathologic characteristics of 78 patients are
summarized in Table 1. Subjects in the ET group were
younger than those in the COT group. The mean age of
the patients was 42.3 ± 7.6years in the ET group and
49.0 ± 10.8years in the COT group (P = 0.003). The
pathological characteristics of both groups, such as the
tumor size (0.5 ± 0.231vs. 0.41 ± 0.264cm, P = 0.116),
number of patients who had thyroid capsular invasion
(3 vs. 4, P = 0.799), number of extrathyroidal extensions
(1 vs. 2, P = 0.618) and number of patients whose




Age (years) 42.3 ± 7.6
Tumor size (cm) 0.5 ± 0.23
Capsule invasion (+/total) 3/37
Extrathyroid (+/total) 1/37
Multiplicity (+/total) 3/37
LN meta (+/total) 5/37
Stage
I/II/III/IV 34/0/3/0
Number of retrieved lymph nodes 3.63 ± 2.1
OP time (min) 138.4 ± 3
Hospital stay (days) 3.35 ± 09
Complications 1
Bleeding 5
Transient vocal cord palsy
Paresthesia
Postoperative pain
VAS 1 4.7 ± 1.7
VAS 7 2.6 ± 1.9
Number of patients with neck discomfort
POD 1 month 6
POD 3 months 3
Cosmesis 1.43 ± 0.5
Recurrence 1
Follow-up period (months) 54.3 ± 21
VAS 1 Visual analog scale 1 day after the operation.
VAS 7 Visual analog scale 7 days after the operation.statistically different. The ET group had more patients
with lymph node metastasis (5 vs. 1), but this didnot
result in a final difference in the stage (according to the
AJCC cancer staging, 7th edition) of both groups
(P = 0.561). There were no statistically significant differ-
ences between the two groups in the number of
retrieved lymph nodes (3.63 ± 2.1 vs. 3.82 ± 3.28,
P = 0.78) and postoperative hospital stay (3.35 ± 0.94vs.
3.17 ± 1.16 days, P = 0.457). However, the operation
time was shorter in the COT group (112.3 ± 14min)
than in the ET group (138.4 ± 36.9 min, P< 0.01). In
terms of postoperative pain, endoscopic thyroidectomy
was more painful(VAS 1; P = 0.037, VAS 7; P = 0.026).
The postoperative complications of both groups were
checked in regard to recurrent laryngeal nerve palsy,
postoperative bleeding, seroma, infection,etc. There was
one postoperative complication in the ET group involv-
ing minor postoperative bleeding,which was treated with
conservative care. One patient experienced transient
vocal cord palsy in the COT group, but this resolved
within 2 months without any treatment. After thee two groups
OPEN P
3:38 0.799
49.0 ± 10.8 0.003







3.82 ± 3.28 0.78
6.9 112.3 ± 14 <0.01
4 3.17 ± 1.16 0.457
1 0.941
2
3.8 ± 1.9 0.037
1.7 ± 1.8 0.026
5 0.748
2 0.664
5 3.21 ± 0.72 <0.001
1 0.667
.7 47.4 ± 13.6 0.1
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ment of the vocal cords by laryngoscope.
The mean follow-up period was 54.3 ± 21.7months in
the ET group and 47.4 ± 13.6months in the COT group.
In the COT group, there was one case of tumor recur-
rence detected at the other thyroid lobe2 years later.
Also, in the ET group, there was one case of recurrence
in the other thyroid lobe 14 months later. The cosmetic
result was evaluated using a scoring system (1, ex-
tremely; 2, fairly; 3,normal; 4, not at all) 6 months after
operation. The postoperative cosmetic resultswere excel-
lent in the ET group, and the small scar left along the
skin crease in the axilla was completely covered by the
patient’s arm in its natural position (Figure 4). In terms
of cosmesis, we found that satisfaction with the cosmetic
aspect of the operative procedure was higher in the ET
group(1.43 ± 0.55vs. 3.21 ± 0.72, P< 0.001).
Discussion
With the development of various surgical techniques
and instruments, endoscopic surgery has been growing
recently and attemptedin various surgical fields. Thyroid
tumors usually occur in women, and the incidence rate
is especially increased in young women. Patients are
interested not only in the treatment of the disease, but
also in the postoperative quality of life, especially con-
cerning the operation scars. Therefore, surgeons have
made efforts to resolve the scarring problem. With
the improvements of laparoscopic instruments and
increased surgeon experience, interest has focused onde-
veloping less invasive instruments and surgical techni-
ques to provide minimally invasive surgery also for theFigure 4 Macroscopic view of the neck and axilla 6 months
after endoscopic thyroidectomy using the axillary approach.thyroid tumors [4]. Endoscopic neck surgery was
attempted by Gagner in 1996 [1]. The first endoscopic
thyroidectomy was performed by Huscher in 1997 [2].
Since then, various methods, including axillary, breast
and anterior chest approaches, have been introduced by
many surgeons [5-7].
Concerning the oncological safety, endoscopic thyroi-
dectomy for malignant thyroid tumors is controversial.
Initially, COT was the treatment of choice for malignant
thyroid tumors [8]. However, papillary thyroid and fol-
licular thyroid carcinomas have a very good prognosis,
and the prognosis is not affected by whether central
lymph node dissection is done [9]. Also, some reports
state that if there is no lymph node metastasis, central
lymph node dissection is not recommended because it
may cause permanent hypoparathyroidism [9]. Other
studies reported that complete thyroidectomy is not al-
ways necessary in patients with papillary thyroid micro-
carcinoma. Thyroid lobectomy alone may be a sufficient
treatment for small (<1cm), low-risk, unifocal, intrathyr-
oidal papillary carcinoma in the absence of prior head
and neck irradiation or radiologically or clinically
involved cervical nodal metastases [10]. The prospective
study of endoscopic thyroidectomy for patients with papil-
lary thyroid microcarcinoma was first done by Miccoli
[11]. Recently, comparative studies of endoscopic thyroi-
dectomy versus conventional open thyroidectomy have
been reported [4,8,12,13]. These comparative studies
reported that there was no significant difference regarding
the technical safety between COT and ET, and theyfound
that ET had many advantages, including better cosmetic
results [12-17].
At first, we applied ET for benign thyroid tumors. As
experience with this method has accumulated, the indi-
cations for ET have been expanded to some cases of thy-
roid malignancies. We used a unilateral axillary
approach for endoscopic thyroidectomy and have ap-
plied it to malignant thyroid disease since 2002.
Many researchers have emphasized the definite indica-
tions and contraindications for endoscopic thyroidect-
omy. Kitano et al. reported the indicationsfor treating
thyroid cancer with endoscopic surgery [18]. The indica-
tions for using endoscopic surgery for thyroid cancer are
as follows: age <45 years, tumor size < 2cm, and no
evidence of lymph node metastasis or local invasion.
Miccoli et al. showed that the completeness of the
results obtained with minimally invasive video-assisted
thyroidectomy for thyroid cancers not exceeding 3.5cm
in diameterwas similar to that obtained with open thyr-
oidectomy [11,19]. Our indications for using endoscopic
thyroidectomy for malignant thyroid disease in this
study were as follows: tumor size not exceeding 1cm on
preoperative ultrasonography; no evidence of lateral
lymph node metastasis or local invasion on preoperative
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ical examination; patient consent was obtained.
Many studies reported that there was no significant
difference in the cervical lymph node dissection tech-
nique and surgical outcome between ET and COT [20-
23]. It might enhance the surgical completeness of ET.
Jeong et al. reported that the average number of
retrieved lymph nodes was 5.05 ±2.94 (1–16) in ET, and
there was no statistical difference compared to COT [4].
Along with the two other studies, the numbers were
5.38 and 3.5, respectively [16,24]. In our study, the num-
bers were 3.63 ± 2.1 in ET and 3.82 ± 3.28 in COT. The
number was relatively small, but there was no statistical
difference. Considering unilateral central lymph node
dissection, it was not too small compared with the num-
ber of recent studies.
The incidence of transient recurrent laryngeal nerve
palsy after conventional open thyroidectomy is reported
to be 0% to 6% and that of permanent recurrent laryn-
geal nerve palsy less than 1% [25,26]. In our procedure,
when the thyroid gland is freed or resected, we operated
in close proximity to the thyroid capsule, and the RLN
and parathyroid gland were magnified on a videoscope.
Therefore, their preservation was easy. We didn’t en-
counter recurrent laryngeal nerve palsy in the ET group,
although in the COT group, there was one patient whose
symptom of transient vocal cord palsy spontaneously
disappeared after 2 months.
Objective evaluation of cosmetic results is difficult at
present. Cosmetic results are difficult to demonstrate
without some bias because of the subjective judgment of
the patients. In our study, cosmetic results were evalu-
ated with a scoring system (1, extremely; 2, fairly; 3,nor-
mal; 4, not at all) 6 months after the operation, and all
of the patients treated by the axillary approach described
in this study were satisfied with their operative scars.
Among the 37 patients who received endoscopic thyroi-
dectomy, 17 were extremely satisfied with their cosmetic
results. Some patients in the ET group complained of
paresthesia, but this also disappeared 3 months after the
operation.
Dhiman et al. reported disadvantages of endoscopic
thyroidectomy with thyroid disease and thyroid cancer
at 2008 [17]: using the equipment requirestwo to three
assistants;there are a steep learning curve and longer
duration of surgery;it isn’t applicable for thyroid glands>
20cc in size;costs are increasedbecause of equipment
usage. The operation time for the COT group in our
study was longer than thetimes reported in the literature
[4,27,28]. We assumed that there were two reasons:
First, we didn’t use drains to improve the patients’ cosm-
esis. Therefore, meticulous bleeding control and careful
lymph node dissection required longer operation times.
Secondly, most operations were performed withoutskilled assistants because of the lack of human resource-
sin our department. Despite the longer operation time in
the COT group than reported in the literature, the oper-
ation time in the ET group in our study was even longer
than that inthe COT group. Recently, we decreased the
operation time in the ET group to about 120 min (data
not shown). We investigated short-term postoperative
pain to evaluate the invasiveness of endoscopic thyroi-
dectomy using the axillary approach. Both groups
showed no significant difference in neck discomfort 3
months after the operation, but endoscopic thyroidect-
omy definitely was more painful than COT in the short
term. We assumed that this disadvantage was due to
wider dissection in the ET group than in the COT group.
To minimize this disadvantage, other methods such as a
single-port surgery will be helpful.
In our study, one case of recurrence occurred in each
group, and we performed completion thyroidectomy. In
terms of multiplicity, there were three cases in the ET
group and five cases in the COT group. All were closely
observed with the patient’s consent and no additional
operations.
As we described, endoscopic thyroidectomy was safe
and effective for treating papillary thyroid microcarci-
noma. According to the literature, endoscopic thyroi-
dectomy is an acceptable method for treating T2
tumors, T3 tumors and lateral neck lymph node dissec-
tion [23,28,29]. According to the results of this study, we
are going to broaden our indications.
Conclusion
Endoscopic thyroid lobectomy with central lymph node
dissection using the axillary approach is a safe, minim-
ally invasive procedure that produces outcomes similar
to those of conventional open thyroidectomy when con-
sidering short-term adverse events.It has the advantage
of achieving better cosmetic results than open thyroi-
dectomy. Although larger randomized controlled trials
with a longer follow-up are needed, endoscopic thyroi-
dectomy is an effective alternative for selected patients
with papillary thyroid microcarcinoma compared to con-
ventional open thyroidectomy.
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